Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Vitamin E succinate (RRR-alpha-tocopheryl succinate,
VES
), an efficient inducer of apoptosis, acts as a potent agent for cancer therapy. However, the mechanism by which
VES
mediates the effects are not yet fully understood. Here we studied the effect of endoplasmic reticulum (ER) stress and unfolded protein response (UPR) on
VES
-induced apoptosis of SGC-7901 human gastric cancer cells.
VES
caused cytological changes typical of apoptosis, increased ER dilation and cytosolic Ca(2+) concentration. And endogenous ER stress markers, GRP78 and GRP94 were transcriptionally and translationally altered. In response to
VES
, induction of CHOP, activation of caspase-4 and JNK were observed. Furthermore,
VES
also triggered activation of UPR components, including RNA-dependent
protein kinase
(PKR)-like ER kinase (PERK), activating transcription factor 6 (ATF6), X-box-binding protein 1 (XBP1), and ATF4 in a concentration- and time-dependent manner. Consequently, our results suggest that
VES
-induced apoptosis is coupled to ER stress and UPR activation in SGC-7901 human gastric cancer cells.
...
PMID:Endoplasmic reticulum stress contributes to vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells. 2043 8